Assignee
SUTRO BIOPHARMA INC
US·52 granted patents·45 pending applications·300 citations·filing 2010–2025
Top patents by PatentIndex Score
97 records- 0197US9840493B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Dec 12, 2017·24 cites·9 claims
- 0297US9682934B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2013·Granted Jun 20, 2017·35 cites·35 claims
- 0395US10112900B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·12 cites·13 claims
- 0495US9988619B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2014·Granted Jun 5, 2018·40 cites·10 claims
- 0594US10596270B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2018·Granted Mar 24, 2020·15 cites·24 claims
- 0694US9938516B2Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanineSUTRO BIOPHARMA INC·Filed 2014·Granted Apr 10, 2018·40 cites·22 claims
- 0794US9764039B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Sep 19, 2017·20 cites·36 claims
- 0893US10450353B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 22, 2019·6 cites·13 claims
- 0992US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 1092US10774354B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2018·Granted Sep 15, 2020·9 cites·29 claims
- 1192US10669347B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·5 cites·16 claims
- 1292US10442789B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 15, 2019·4 cites·11 claims
- 1392US9738724B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 22, 2017·12 cites·35 claims
- 1491US10190145B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2014·Granted Jan 29, 2019·12 cites·20 claims
- 1591US10179909B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2018·Granted Jan 15, 2019·5 cites·10 claims
- 1691US9994527B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 12, 2018·6 cites·15 claims
- 1791US9732161B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 15, 2017·7 cites·20 claims
- 1890US11261219B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 1, 2022·4 cites·15 claims
- 1989US10730837B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·27 claims
- 2089US9650621B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2013·Granted May 16, 2017·10 cites·13 claims
- 2188US12269801B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2022·Granted Apr 8, 2025·0 cites·17 claims
- 2288US11548852B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2020·Granted Jan 10, 2023·1 cites·26 claims
- 2388US10501558B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·20 claims
- 2487US10648010B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2016·Granted May 12, 2020·4 cites·19 claims
- 2584US2025236594A1Modified amino acidsSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2683US11958909B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2020·Granted Apr 16, 2024·1 cites·20 claims
- 2783US11408021B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2020·Granted Aug 9, 2022·1 cites·10 claims
- 2883US2025002604A1Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2982US11708413B2Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2017·Granted Jul 25, 2023·3 cites·29 claims
- 3082US10316322B2High growth capacity auxotrophic Escherichia coli and methods of useSUTRO BIOPHARMA INC·Filed 2015·Granted Jun 11, 2019·4 cites·23 claims
- 3182US2025090676A1Anti-folate receptor alpha antibody conjugates and their usesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3281US11098107B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2017·Granted Aug 24, 2021·2 cites·25 claims
- 3381US2025346650A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 3479US10487133B2Codon optimization for titer and fidelity improvementSUTRO BIOPHARMA INC·Filed 2015·Granted Nov 26, 2019·2 cites·26 claims
- 3578US2024254163A1Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3677US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 3777US12098406B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2022·Granted Sep 24, 2024·0 cites·28 claims
- 3877US9896685B2Use of LAMBDA-GAM protein in ribosomal display technologySUTRO BIOPHARMA INC·Filed 2014·Granted Feb 20, 2018·1 cites·9 claims
- 3977US2024010715A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4077US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4175US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 4275US11407975B2E. coli strains having an oxidative cytoplasmSUTRO BIOPHARMA INC·Filed 2019·Granted Aug 9, 2022·1 cites·29 claims
- 4374US11993658B2Anti-BCMA antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2019·Granted May 28, 2024·1 cites·16 claims
- 4474US2025304723A1Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 4573US2024409630A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4672US12427201B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·27 claims
- 4772US12398197B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2021·Granted Aug 26, 2025·0 cites·16 claims
- 4872US12252552B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 18, 2025·0 cites·32 claims
- 4972US10844090B2Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2016·Granted Nov 24, 2020·1 cites·16 claims
- 5072US2026078337A1E. coli strains having an oxidative cytoplasmSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →